Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 USD | -0.83% | -11.19% | +196.02% |
Mar. 28 | Perspective Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | North American Morning Briefing : Markets Steady -2- | DJ |
Chart calendar Perspective Therapeutics, Inc.
Upcoming events on Perspective Therapeutics, Inc.
Past events on Perspective Therapeutics, Inc.
2024-03-28 07:30 am | Q4 2023 Earnings Release |
2024-03-18 10:00 am | Analyst Day |
2024-03-01 02:30 pm | B. Riley Securities Radiopharma Day - Panel |
2024-03-01 01:45 pm | B. Riley Securities Radiopharma Day - Panel |
2024-03-01 10:00 am | B. Riley Securities Radiopharma Day - Panel |
2024-02-28 11:00 am | Investor Meeting |
2024-02-14 11:20 am | Oppenheimer Healthcare Life Sciences Conference |
2024-01-11 03:00 pm | JPMorgan Healthcare Conference |
2024-01-08 01:30 pm | Biotech Showcase |
2024-01-07 | BIO Partnering JPM Conference |
2024-01-07 05:30 pm | BFC Global HealthCare BD & Investment Conference |
2024-01-07 12:15 pm | BFC Global HealthCare BD & Investment Conference - Panel |
2023-11-14 04:25 pm | Q3 2023 Earnings Release |
2023-10-05 | Annual General Meeting |
2023-10-03 | North American Neuroendocrine Tumor Society Symposium - Phase 1/2 Trial of Pb-212-VMT |
2023-10-03 | North American Neuroendocrine Tumor Society Symposium - Phase 1 Trial of Pb-212-VMT |
2023-09-30 | American Society for Radiation Oncology Conference |
2023-09-12 03:45 am | European Association of Nuclear Medicine Congress - Abstract Number: OP-673 |
2023-09-10 09:00 am | European Association of Nuclear Medicine Congress - Abstract Number: OP-144 |
2023-09-07 05:00 am | World Molecular Imaging Congress - Abstract No : 131 |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 5,92 5,87 0.97% | 7,31 7,41 -1.35% | 9,68 10,1 -4.08% | 10,1 10,0 0.2% | 3,55 | 1,43 8,46 -83.04% |
EBITDA Million USD | Released Forecast Spread | -6,60 -5,60 -17.84% | -5,07 -5,10 0.63% | -2,87 -3,10 7.45% | -2,87 -2,80 -2.64% | 0,00 | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -6,73 -5,99 -12.29% | -5,25 -5,62 6.45% | -3,55 -3,40 -4.28% | -3,45 -3,29 -4.62% | 0,00 | -40,9 -43,4 5.6% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,70 -5,97 -12.27% | -5,14 -5,53 6.92% | -3,45 -3,39 -1.77% | -3,39 -3,30 -2.64% | 0,00 | -40,1 -43,0 6.64% |
Net income Million USD | Released Forecast Spread | -6,71 -5,97 -12.39% | -5,16 -5,53 6.72% | -3,46 -3,39 -2.1% | -3,39 -3,25 -4.3% | 0,00 | -46,5 -37,7 -23.33% |
EPS USD | Released Forecast Spread | -0,12 -0,11 -12.5% | -0,08 -0,09 5.88% | -0,05 -0,05 -11.11% | -0,03 -0,03 -12.49% | -0,05 | -0,17 -0,14 -21.43% |
Announcement Date | 25/09/18 | 24/09/19 | 17/09/20 | 21/09/21 | 01/05/23 | 28/03/24 |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2,60 2,41 7.68% | 2,71 2,70 0.37% | 2,06 | 2,09 2,61 -20% | 1,91 2,20 -13.23% | -4,90 2,12 -331.06% | 1,98 | 0,00 | 0,00 | 0,12 |
EBITDA Million USD | Released Forecast Spread | -0,72 -0,70 -3% | -0,92 -0,80 -14.5% | ||||||||
EBIT Million USD | Released Forecast Spread | -0,77 -0,80 4.31% | -1,09 -0,91 -20.2% | -11,4 -7,66 -48.56% | -10,5 -10,3 -2.57% | -7,81 -10,2 23.79% | |||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -0,75 -0,80 6.88% | -1,06 -0,90 -17.89% | -11,1 -7,65 -45.21% | -10,4 -10,3 -0.92% | -7,77 -10,7 27.11% | -10,9 | -10,6 | -10,8 | -11,1 | |
Net income Million USD | Released Forecast Spread | -0,75 -0,80 6.58% | -1,06 -0,91 -16.94% | -11,1 -7,65 -45.16% | -10,4 -10,3 -0.89% | -24,7 -10,7 -131.35% | -10,9 | -10,6 | -10,8 | -11,1 | |
EPS USD | Released Forecast Spread | -0,01 -0,01 0% | -0,01 -0,01 0% | 0,00 | -0,04 -0,03 -33.33% | -0,04 -0,04 0% | -0,09 -0,04 -125% | -0,04 | -0,03 | -0,03 | -0,03 |
Announcement Date | 13/05/21 | 21/09/21 | 15/05/23 | 11/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
2024-04-07 | MANI, INC.: Q2 2024 Earnings Release |
2024-04-08 | NEOGEN CORPORATION: Q3 2024 Earnings Release |
2024-04-08 | NINGBO DAVID MEDICAL DEVICE CO., LTD.: Q4 2023 Earnings Release |
2024-04-11 01:00 am | GERRESHEIMER AG: Q1 2024 Earnings Release |
2024-04-15 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q4 2023 Earnings Release |
2024-04-16 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-17 07:30 am | ABBOTT LABORATORIES: Q1 2024 Earnings Release |
2024-04-17 | WELL LEAD MEDICAL CO., LTD.: Q1 2024 Earnings Release (Projected) |
2024-04-18 01:00 am | SARTORIUS STEDIM BIOTECH: Q1 2024 Earnings Release |
2024-04-18 08:00 am | ARJO AB: Q1 2024 Earnings Release |
Past sector events for Perspective Therapeutics, Inc.
Today | SHINVA MEDICAL INSTRUMENT CO.,LTD.: Q4 2023 Earnings Release |
2024-03-28 07:30 am | PERSPECTIVE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-22 | JIANGXI SANXIN MEDTEC CO.,LTD.: Q4 2023 Earnings Release |
2024-03-18 | HLB CO., LTD.: Q4 2023 Earnings Release (Projected) |
2024-03-13 02:00 am | MEDACTA GROUP SA: Q4 2023 Earnings Release |
2024-03-07 | SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
2024-03-07 07:00 am | AMPLIFON S.P.A.: Q4 2023 Earnings Release |
2024-03-07 06:30 am | STEVANATO GROUP S.P.A.: Q4 2023 Earnings Release |
2024-03-06 02:00 am | CONVATEC GROUP PLC: Q4 2023 Earnings Release |
2024-03-05 04:05 pm | AGILITI, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Perspective Therapeutics, Inc. - Nyse
- Calendar Perspective Therapeutics, Inc.